The Coalition and American Hospital Association, AdventHealth, Atalan, and Providence’s Well Being Trust collaborate on practical framework for healthcare initiative evaluation ALTAMONTE SPRINGS, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- The Coalition for Physician & APP Well-Being, a non-profit entity comprised of national healthcare organizations dedicated to fostering the well-being…
Read More
PHILADELPHIA, June 25, 2026 (GLOBE NEWSWIRE) -- Nurse burnout remains a significant challenge in the healthcare industry, with growing interest in tools that can help identify retention risk earlier. Atalan for Nursing is intended to address this need. Atalan, the leading Clinician Retention Intelligence (CRI) platform, today announced the launch…
Read More
BCI’s second investment to advance therapeutic treatments for celiac disease will support preclinical development of novel approach to immune tolerance AMBLER, PA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, today announced an investment in Tolerance Bio Inc., to support…
Read More
Established biopharmaceutical executive with more than 25 years of business development, corporate strategy, financing, and transaction experience Demonstrated leader in gene therapy and CNS drug development Appointment comes as Latus enters the clinic, with LTS-201 for Huntington’s disease on track for IND submission in 3Q 2026 PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus…
Read More
Elsevier's ClinicalKey Al and Wei/sheet will deliver verifiable clinical evidence and patient context directly into the EHR, giving clinicians governed Al answers within their existing workflows NEW YORK, June 3, 2026 /PRNewswire/ -- Elsevier today announced it has acquired Wellsheet, a US-based health technology company that specializes in aggregating and…
Read More
lmmuno-oncology leader brings more than three decades of experience advancing innovative cancer therapies across biotech, pharma, and the National Cancer Institute HOUSTON, May 28, 2026 /PRNewswire/ -- lmmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced the appointment of Claudio Dansky Ullmann, M.D. as Chief Medical Officer. Dr…
Read More
Two appointments add drug development and defense-sector expertise to Ladder Bio’s Board as the company advances its Spiroligomer™ platform BLUE BELL, Pa.--(BUSINESS WIRE)--Ladder Bio, Inc., a structure-guided biotechnology company developing Spiroligomers™, a new class of chemical matter as medicines, today announced the appointments of Jay Fine, PhD, and John Prufeta…
Read More
Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus platform from LTS-101 in CLN2 disease expected in 4Q 2026; multiple fast follow-ons utilize the same capsid for larger indications Proprietary engineered AAV…
Read More
Computational and preclinical data support advancement of LTS-201 and LTS-101 programs into clinic later this year Latus founder Beverly Davidson, Ph.D., awarded the ASGCT Outstanding Achievement Award – the Society’s highest honor PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad patient populations, today…
Read More
The Economic Times, US Story by Maitreyee Thakkar, Global Desk For decades, advances in battlefield medicine have focused on one goal: keep the wounded alive long enough to reach a surgical facility. Tourniquets, hemostatic dressings, rapid evacuation, and forward surgical teams dramatically improved survival in Iraq and Afghanistan. Yet one…
Read More
The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis with proven remote spirometry and FeNO capabilities - creating a unique, single-partner endpoint solution for respiratory sponsors. PHILADELPHIA, PA / ACCESS Newswire / April 16, 2026 / Strados Labs, the respiratory endpoint intelligence company, today announced the…
Read More
Presentation details the IND-enabling work for IMGS-203, a potent Stimulator of Interferon Genes (STING) Agonist, for the treatment of Glioblastoma Multiforme (GBM) Houston, Texas, April 15, 2026 /PR Newswire/— ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced that it will present a poster at the upcoming American…
Read More
Leveraging AI-Driven Multiomics and Spatial Biology to Unlock the Full Potential of Next-Generation Cytotoxic Dual Checkpoint Inhibitor WALTHAM, Mass. & HOUSTON--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, and ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced a strategic partnership to accelerate…
Read More
THE WOODLANDS, Texas and HUMMELSTOWN, Pa., March 17, 2026 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with BobcatBio, a clinical-stage biotechnology company that is pioneering the development of RB-1355, a first of its kind cellular therapy that leverages the versatility and…
Read More
IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced its participation in the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting. IVIEW will present one oral presentation and four posters highlighting advancments in dry eye, gene therapy, ocular…
Read More
IVIEW Therapeutics Inc. (“IVIEW”), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative ophthalmic therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to initiate a Phase 3 clinical trial for IVIEW-1701. IVIEW-1701 is an innovative drug…
Read More
Becomes go-to AI intelligence layer and clinical decision support tool across 100+ hospitals NEWARK, N.J., Feb. 19, 2026 /PRNewswire/ -- Wellsheet, a leader in AI clinical workflows and operations, was recently named one of 2025's most promising startups. Wellsheet is gaining traction as hospitals grapple with clinician burnout and data overload. Its technology is live…
Read More
Implanting Clinicians, Dr. Sean Lyden, Dr. Bao Bui, Professor Dainis Krievins, Dr. Dai Yamanouchi, Dr. Venkatesh Ramaiah, Professor Ramon Varcoe, Dr. Shannon Thomas and Professor Andrew Holden will author a paper highlighting these positive outcomes from 14 first-in-human patients. West Chester, PA — February 19, 2026 — VESTECK today announced…
Read More
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Keriton, a market leader in innovative cloud-based software that streamlines breast milk and formula management and supports safe feeding practices, announced today that it has been acquired by Natus Sensory, a global leader in sensory and newborn care solutions. Keriton will become part of Natus Sensory’s Newborn Care portfolio,…
Read More
The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD exacerbations. Enrollment started in January. PHILADELPHIA, PA / ACCESS Newswire / January 28, 2026 / Strados Labs, a medical technology company advancing respiratory care through wearable…
Read More